Leading scientific researchers from the University of Oxford have said that the antiviral medication hydroxychloroquine is being ‘discarded prematurely’ and could still have benefit against COVID-19.
The first UK frontline NHS worker will today enrol in a new study designed to test the potential of hydroxychloroquine to prevent infection with novel coronavirus.